Amita Shukla is an innovator and entrepreneur focused on discovering, developing, and scaling simple yet powerful ideas for human well-being. She is the founder and CEO of Vitamita and the author of Enduring Edge. Previously, she was a principal at New Enterprise Associates, one of the world’s largest and most active venture capital firms with over $13 billion in committed capital, where she evaluated medical innovations and invested in healthcare startups for close to nine years. Earlier, she was the vice president of AmiKa Corp., a biomedical technology company where she developed and commercialized novel research tools—for which she holds 10 issued patents—until its acquisition by Harvard Bioscience (Nasdaq: HBIO). Shukla regularly mentors startups, advises organizations, and speaks to audiences of innovators, entrepreneurs, and leaders in industry, academia, government, and the military. In 2015, she was appointed as a Mentor in Residence at Johns Hopkins University to help its researchers and physicians realize the potential of their groundbreaking discoveries. She has served on the Johns Hopkins Medicine Alliance for Science and Technology Development since 2007. In 2010, she was Governor Martin O’Malley’s youngest appointee to the board of Maryland’s Technology Development Corporation (TEDCO), a national leader in seed/early-stage investing. In 2015, she was reappointed by Governor Larry Hogan. Shukla has a BA in biochemistry from Harvard, where she was a Senior Editor at The Harvard Crimson, and an MBA from Stanford.